Patent · US Active

Estrogen receptor mutations and uses thereof

US10093983B2 · kind B2 · utility

1Cited by

0References

26Claims

0Family size

Assignee

Foundation Medicine, Inc. · US

Inventors

Maureen T. Cronin · Los Altos, US
Garrett Michael Frampton · Somerville, US
Doron Lipson · Cambridge, US
Vincent A. Miller · New York, US
Gary Palmer · Waltham, US
Jeffrey S. Ross · Lancaster, US
Philip James Stephens · Lexington, US
Roman Yelensky · Newton, US

Key dates

Filing date	Jun 29, 2015
Grant date	Oct 9, 2018
Priority date	—
Expiry date	Jun 29, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel mutant ESR1 molecules and uses are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.